201 related articles for article (PubMed ID: 24788224)
1. ApoE-deficient promotes blood-brain barrier disruption in experimental autoimmune encephalomyelitis via alteration of MMP-9.
Zheng M; Wei J; Tang Y; Yang C; Wei Y; Yin X; Liu Q
J Mol Neurosci; 2014; 54(2):282-90. PubMed ID: 24788224
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol defends blood-brain barrier integrity in experimental autoimmune encephalomyelitis mice.
Wang D; Li SP; Fu JS; Zhang S; Bai L; Guo L
J Neurophysiol; 2016 Nov; 116(5):2173-2179. PubMed ID: 27535376
[TBL] [Abstract][Full Text] [Related]
3. Idazoxan reduces blood-brain barrier damage during experimental autoimmune encephalomyelitis in mouse.
Wang XS; Fang HL; Chen Y; Liang SS; Zhu ZG; Zeng QY; Li J; Xu HQ; Shao B; He JC; Hou ST; Zheng RY
Eur J Pharmacol; 2014 Aug; 736():70-6. PubMed ID: 24797785
[TBL] [Abstract][Full Text] [Related]
4. Bexarotene reduces blood-brain barrier permeability in cerebral ischemia-reperfusion injured rats.
Xu L; Cao F; Xu F; He B; Dong Z
PLoS One; 2015; 10(4):e0122744. PubMed ID: 25844636
[TBL] [Abstract][Full Text] [Related]
5. Blood-brain barrier alterations in the cerebral cortex in experimental autoimmune encephalomyelitis.
Errede M; Girolamo F; Ferrara G; Strippoli M; Morando S; Boldrin V; Rizzi M; Uccelli A; Perris R; Bendotti C; Salmona M; Roncali L; Virgintino D
J Neuropathol Exp Neurol; 2012 Oct; 71(10):840-54. PubMed ID: 23001217
[TBL] [Abstract][Full Text] [Related]
6. The anti-inflammatory effect of donepezil on experimental autoimmune encephalomyelitis in C57 BL/6 mice.
Jiang Y; Zou Y; Chen S; Zhu C; Wu A; Liu Y; Ma L; Zhu D; Ma X; Liu M; Kang Z; Pi R; Peng F; Wang Q; Chen X
Neuropharmacology; 2013 Oct; 73():415-24. PubMed ID: 23831366
[TBL] [Abstract][Full Text] [Related]
7. RGMa Participates in the Blood-Brain Barrier Dysfunction Through BMP/BMPR/YAP Signaling in Multiple Sclerosis.
Zhang L; Tang S; Ma Y; Liu J; Monnier P; Li H; Zhang R; Yu G; Zhang M; Li Y; Feng J; Qin X
Front Immunol; 2022; 13():861486. PubMed ID: 35664003
[TBL] [Abstract][Full Text] [Related]
8. Endothelial α6β4 integrin protects during experimental autoimmune encephalomyelitis-induced neuroinflammation by maintaining vascular integrity and tight junction protein expression.
Welser JV; Halder SK; Kant R; Boroujerdi A; Milner R
J Neuroinflammation; 2017 Nov; 14(1):217. PubMed ID: 29121970
[TBL] [Abstract][Full Text] [Related]
9. 2-(2-Benzofuranyl)-2-Imidazoline Attenuates the Disruption of the Blood-Brain Barrier in EAE via NMDAR.
Xia N; Hua Y; Li J; Chen Y; Li X; Lin J; Xu H; Xie C; Wang X
Neurochem Res; 2021 Jul; 46(7):1674-1685. PubMed ID: 33772673
[TBL] [Abstract][Full Text] [Related]
10. Potential implications of Apolipoprotein E in early brain injury after experimental subarachnoid hemorrhage: Involvement in the modulation of blood-brain barrier integrity.
Pang J; Wu Y; Peng J; Yang P; Kuai L; Qin X; Cao F; Sun X; Chen L; Vitek MP; Jiang Y
Oncotarget; 2016 Aug; 7(35):56030-56044. PubMed ID: 27463015
[TBL] [Abstract][Full Text] [Related]
11. Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis.
Tietz S; Périnat T; Greene G; Enzmann G; Deutsch U; Adams R; Imhof B; Aurrand-Lions M; Engelhardt B
Brain Behav Immun; 2018 Oct; 73():3-20. PubMed ID: 29920328
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase-2 and -9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins.
Feng S; Cen J; Huang Y; Shen H; Yao L; Wang Y; Chen Z
PLoS One; 2011; 6(8):e20599. PubMed ID: 21857898
[TBL] [Abstract][Full Text] [Related]
13. Effects of fumaric acid esters on blood-brain barrier tight junction proteins.
Bénardais K; Pul R; Singh V; Skripuletz T; Lee DH; Linker RA; Gudi V; Stangel M
Neurosci Lett; 2013 Oct; 555():165-70. PubMed ID: 24076006
[TBL] [Abstract][Full Text] [Related]
14. Defining the role of NG2-expressing cells in experimental models of multiple sclerosis. A biofunctional analysis of the neurovascular unit in wild type and NG2 null mice.
Girolamo F; Errede M; Longo G; Annese T; Alias C; Ferrara G; Morando S; Trojano M; Kerlero de Rosbo N; Uccelli A; Virgintino D
PLoS One; 2019; 14(3):e0213508. PubMed ID: 30870435
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase Cβ as a therapeutic target stabilizing blood-brain barrier disruption in experimental autoimmune encephalomyelitis.
Lanz TV; Becker S; Osswald M; Bittner S; Schuhmann MK; Opitz CA; Gaikwad S; Wiestler B; Litzenburger UM; Sahm F; Ott M; Iwantscheff S; Grabitz C; Mittelbronn M; von Deimling A; Winkler F; Meuth SG; Wick W; Platten M
Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14735-40. PubMed ID: 23959874
[TBL] [Abstract][Full Text] [Related]
16. TGFβ1 exacerbates blood-brain barrier permeability in a mouse model of hepatic encephalopathy via upregulation of MMP9 and downregulation of claudin-5.
McMillin MA; Frampton GA; Seiwell AP; Patel NS; Jacobs AN; DeMorrow S
Lab Invest; 2015 Aug; 95(8):903-13. PubMed ID: 26006017
[TBL] [Abstract][Full Text] [Related]
17. The protective effects of bioactive (RS)-glucoraphanin on the permeability of the mice blood-brain barrier following experimental autoimmune encephalomyelitis.
Giacoppo S; Galuppo M; Iori R; De Nicola GR; Bramanti P; Mazzon E
Eur Rev Med Pharmacol Sci; 2014; 18(2):194-204. PubMed ID: 24488908
[TBL] [Abstract][Full Text] [Related]
18. Blood-brain barrier disruption and enhanced vascular permeability in the multiple sclerosis model EAE.
Bennett J; Basivireddy J; Kollar A; Biron KE; Reickmann P; Jefferies WA; McQuaid S
J Neuroimmunol; 2010 Dec; 229(1-2):180-91. PubMed ID: 20832870
[TBL] [Abstract][Full Text] [Related]
19. Experimental autoimmune encephalomyelitis and age-related correlations of NADPH oxidase, MMP-9, and cell adhesion molecules: The increased disease severity and blood-brain barrier permeability in middle-aged mice.
Seo JE; Hasan M; Han JS; Kang MJ; Jung BH; Kwok SK; Kim HY; Kwon OS
J Neuroimmunol; 2015 Oct; 287():43-53. PubMed ID: 26439961
[TBL] [Abstract][Full Text] [Related]
20. Blood-brain barrier genetic disruption leads to protective barrier formation at the Glia Limitans.
Mora P; Hollier PL; Guimbal S; Abelanet A; Diop A; Cornuault L; Couffinhal T; Horng S; Gadeau AP; Renault MA; Chapouly C
PLoS Biol; 2020 Nov; 18(11):e3000946. PubMed ID: 33253145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
